STAGE II NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE II NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE II NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy for lung cancer shows promise in early safety trial
Disease control CompletedThis early-stage trial tested adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation for people with stage II to IIIB non-small cell lung cancer. The main goal was to find the safest dose and identify side effects, especially severe lung inflammation. …
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Experimental combo shows promise in Tough-to-Treat lung cancer
Disease control CompletedThis study tested a new combination treatment for people with advanced non-small cell lung cancer that had already been treated. The treatment combined a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) to help the immune system fight the cancer. The trial included …
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 26, 2026 11:59 UTC